Therapeutic Asset Ratings
19,639 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Olaparib
BRCA1-Related Cancer Predisposition
M.D. Anderson Cancer Center
P2
BB
(69)
Palbociclib
Soft Tissue Sarcoma
Brown University
P2
BB
(69)
Pembrolizumab
Metastatic Prostate Carcinoma
CuraCell TX AB
P2
BB
(69)
PREDNISONE TABLETS
Burkitt Lymphoma
AIDS Malignancy Consortium
P2
BB
(69)
PREDNISONE TABLETS
Post-transplant Lymphoproliferative Disorder
Washington University School of Medicine
P2
BB
(69)
Pri-724
Cirrhosis Of Liver
Kiminori Kimura, MD
P2
BB
(69)
Rapamycin
Myelodysplastic/Myeloproliferative Neoplasm
OHSU Knight Cancer Institute
P2
BB
(69)
Rencofilstat
NASH With Fibrosis
Hepion Pharmaceuticals, Inc.
P2
BB
(69)
Romidepsin
Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma
M.D. Anderson Cancer Center
P2
BB
(69)
Sitagliptin
Myelodysplastic Syndrome
Indiana University
P2
BB
(69)
TACROLIMUS
Leukemia, Myeloid, Accelerated-Phase
University of Michigan Rogel Cancer Center
P2
BB
(69)
TACROLIMUS
Adult Acute Lymphoblastic Leukemia
Sumithira Vasu
P2
BB
(69)
TACROLIMUS
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of Minnesota
P2
BB
(69)
TACROLIMUS
Recurrent Adult Diffuse Large Cell Lymphoma
University of Michigan Rogel Cancer Center
P2
BB
(69)
TACROLIMUS
Recurrent Adult Lymphoblastic Lymphoma
St. Petersburg State Pavlov Medical University
P2
BB
(69)
TACROLIMUS
Marginal Zone Lymphoma
Masonic Cancer Center, University of Minnesota
P2
BB
(69)
TACROLIMUS
T-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P2
BB
(69)
TEONANACATL
Depressive Disorder
Yale University
P2
BB
(69)
Thiotepa
Chronic Myeloid Leukemia
Leland Metheny
P2
BB
(69)
TIL
Metastatic Melanoma
East Metropolitan Health Service, Australia
P2
BB
(69)
(+)-VINCRISTINE
Malignant Glioma
Kailin Yang, MD, PhD
P2
BB
(69)
(+)-VINCRISTINE
Melanoma (Skin)
GI Innovation, Inc.
P2
BB
(69)
Ziv-Aflibercept
Ovarian Carcinoma
National Cancer Institute (NCI)
P2
BB
(69)
Abemaciclib
Hormone Receptor Positive Tumor
Relay Therapeutics, Inc.
P2
BB
(68)
Bortezomib
B-Cell Non-Hodgkin Lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P2
BB
(68)
Showing 301 to 325 of 19,639 assets
Previous
Page 13 of 786
Next